Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Continuous vs Intermittent Vancomycin Infusion in Critically Ill Patients
NCT03438214Phase 4Unknown
- Sponsor
- Universidade de São Paulo
- Start
- Apr 2018
- Primary completion
- Feb 2020
- Modality
- Cyclic Peptides, Antimicrobial Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of vancomycin in Gram-positive bacterial infection, sepsis, sponsored by Universidade de São Paulo. Status: unknown.
02
Drugs
vancomycin
03
Conditions
Gram-positive bacterial infectionsepsis
Beyond the preview
Go deeper on NCT03438214.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03438214.